Sharma, A, Kaiser, PK, Tadayoni, R, Holz, FG, Nicholson, L, Vazquez-Alfageme, C, Sivaprasad, S, Wakabayashi, T, Woo, SJ, Sarraf, D, Kumar, N, Parachuri, N, Regillo, CD, Rezaei, KA, Khanani, AM, Bandello, F, Shanamugam, M, Verma, L, Dogra, MR, NS, M, Agarwal, M, Loewenstein, A, Kuppermann, BD, Querques, G, Sheth, J, Ayachit, S, Mishra, C, Chakraborty, D, Banker, A, Özdek, Ş, Laurent, K, Bilgic, A, Lanzetta, P, Baumal, C, Holekemp, N, Sakamoto, T, Tufail, A, Yannuzzi, N, Corradetti, G, Boyer, D, Rachitskaya, A
, Peto, T, Wintergerst, MWM, Sarao, V, Parolini, B, Mruthyunjaya, P, Nguyen, QD, Do, DV, Keane, PA, Hassan, T & International Retina Biosimilar Study Group (Inter BIOS Group) 2024, '
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)',
Eye (Basingstoke), vol. 38, pp. 3392-3395.
https://doi.org/10.1038/s41433-024-03284-x